On May 26, 2026, the South Korean stock market found itself at a crossroads, with the KOSPI index surging past the 8,000-point milestone, continuing a remarkable rally, while the KOSDAQ index struggled to break free from its stubborn trading range. This divergence, or "decoupling," between the nation’s two main stock indices has captured the attention of investors, analysts, and policymakers alike, raising questions about the underlying strengths and future prospects of Korea’s corporate landscape.
According to Seoul Economic Daily, the Korean Exchange’s latest analysis of its “potential measurement index”—a metric that quantifies a company’s future growth prospects by evaluating growth, scale, and profitability—reveals a stark contrast between KOSPI and KOSDAQ constituents. The KOSPI, home to many of Korea’s blue-chip giants, is flush with companies demonstrating both robust growth and solid profitability. Samsung Electronics, for example, led the pack with a potential index of 19.17, followed by SK Hynix at 11.54, Industrial Bank of Korea at 6.82, Hyundai Motor at 5.75, and Kia at 5.17. Notably, 40 KOSPI-listed companies boasted a potential index above 1, signaling broad-based strength among large-cap stocks in sectors like semiconductors, automobiles, and finance.
Meanwhile, the KOSDAQ—often regarded as Korea’s marketplace for growth and innovation—painted a less rosy picture. Only a handful of KOSDAQ stocks managed to achieve a potential index above 1: Olix (2.00), Bitmax (1.85), Oscotec (1.24), and Samhwa Networks (1.11). Most others, including top market cap names like EcoProBM (0.22), EcoPro (0.28), and Alteogen (0.23), lagged behind, with their scores stuck below 1. This suggests that even KOSDAQ’s most prominent companies are struggling to match the growth and profitability seen on the KOSPI, a fact that has not gone unnoticed by market watchers.
The numbers tell a compelling story. Since the start of the year, the KOSPI has rocketed 86.73% higher, while the KOSDAQ has managed a more modest gain of 24%. On May 26, KOSDAQ opened at 1,189.28, briefly broke above the psychologically important 1,200-point level, but ultimately closed lower at 1,172.52. This performance gap is not just a blip—it’s a reflection of deeper, structural differences between the two markets, as experts point out.
One key concern is valuation. The average 12-month forward price-earnings ratio (PER) for KOSDAQ companies sits at a lofty 27.4 times, meaning that investors are paying more than 27 times expected earnings for these stocks. Such high valuations, especially in an environment where interest rates could rise, put additional pressure on KOSDAQ’s growth-oriented firms. As Lee Hwajin, a researcher at Hyundai Motor Securities, explained to Seoul Economic Daily, “Since 2024, KOSPI and KOSDAQ have shown decoupling due to fundamental differences, with earnings strength concentrated on KOSPI.” In other words, the gap isn’t just about price—it’s about the very ability of companies to generate profits in a changing world.
But the story doesn’t end there. On May 22, 2026, the KOSDAQ index experienced a dramatic 5% surge, closing at around 1,191 points. This was in stark contrast to the KOSPI’s more modest 0.41% rise to 7,848 points the same day. The catalyst? The launch of a massive 7 trillion KRW National Growth Fund, which quickly absorbed 600 billion KRW in public allocation on its first day, according to Energy Economy News. This policy-driven momentum fueled a buying frenzy, with foreign investors purchasing about 600 billion KRW and domestic institutions adding another 290 billion KRW to KOSDAQ holdings.
The beneficiaries were clear: growth sectors like pharmaceuticals, biotechnology, robotics, and aerospace saw outsized gains. Pharmaceutical stocks HLB (+8.8%), ABL Bio (+9.4%), and Rigachem Bio (+12.8%) all posted impressive jumps. Secondary battery makers EcoPro and EcoProBM each soared more than 12%, while Enchem surged 11.1%. Defense contractors LIG Nex1 and Hyundai Rotem also joined the rally, rising 7.3% and 5.4%, respectively. This sector-wide “heat” was a sharp reversal from the recent dominance of semiconductors and automotive stocks, which took a breather as investors rotated into previously overlooked growth names.
Yet, not everyone is convinced that KOSDAQ’s rally marks the start of a new era. Analysts at Yuanta Securities characterized the recent surge as a technical rebound from oversold conditions, rather than a true trend reversal. They pointed to the KOSDAQ’s relative strength index (RSI) of 31—just above the oversold threshold of 30—as evidence that bargain hunters were snapping up undervalued shares. “The KOSDAQ’s recent surge is better understood as a technical rebound and event-driven buying,” they noted. The impact of the National Growth Fund, while significant, was seen as a short-term boost rather than a game-changer.
Meanwhile, external factors continue to weigh on both markets. Geopolitical risks, especially the ongoing negotiations between the United States and Iran—mediated by Pakistan—have kept investors on edge. As reported by Energy Economy News, international crude oil prices (WTI) fell below $100 per barrel, easing some volatility, but uncertainty remains. U.S. President Donald Trump’s demand for Iran to export its highly enriched uranium has met with staunch resistance from Iran’s Supreme Leader Ayatollah Mojtaba Khamenei, leaving the outcome of talks in limbo.
Foreign investor sentiment is another wild card. On May 22, foreign investors sold 1.9266 trillion KRW worth of KOSPI shares, marking their twelfth consecutive day of net selling. The dollar-won exchange rate climbed to 1,517 KRW, making Korean assets less attractive to overseas buyers. While individuals and institutions stepped in to buy 1.0638 trillion KRW and 760.1 billion KRW, respectively, analysts warn that sustained foreign outflows could limit further gains.
Looking ahead, government support for KOSDAQ is expected to continue, with additional policies and events—such as the upcoming ASCO conference in early June—likely to spur short-term buying. However, as Yuanta Securities’ Lee Jaewon cautioned, “For a long-term trend change, concrete license-out announcements from major biotech firms are needed.” In other words, policy and technical rallies can only take the market so far; real, sustainable growth must come from companies delivering on their promises.
As Korea’s financial markets navigate these choppy waters, the gap between KOSPI and KOSDAQ remains a central theme. While blue-chip stalwarts continue to power the main board higher, the junior market’s fate may hinge on its ability to turn potential into performance—and on whether investors are willing to keep paying a premium for the promise of future growth.